Simtra BioPharma Solutions, a contract development and manufacturing organization (CDMO) specializing in sterile injectables, has appointed Dr. Mike Schaefers, Ph.D., as Chief Commercial Officer and Head of Business Development.
 
In this role, Schaefers will oversee global commercial operations, driving business growth, enhancing customer relationships, and leading the company’s market expansion efforts.
 
“Dr. Mike Schaefers has a unique blend of strategic insight and hands-on operational expertise,” said Franco Negron, CEO of Simtra BioPharma Solutions. “Mike understands the complexities of our industry and will be a key driver in our efforts to enhance our market presence and deliver exceptional value to our clients.”

About Dr. Schaefers

Schaefers brings extensive experience from leadership roles at LTS Lohmann Therapie-Systeme AG, Aenova Holding GmbH, and West Pharmaceutical Services. At LTS, he served as Chief Commercial Officer and managed a global team across Germany, the U.S., and China. Throughout his career, he has developed strategies that contributed to business growth, managed business collaborations as well as partnerships, and led key acquisitions and integration activities.
 
Holding a Ph.D. in Inorganic Chemistry from Ruhr University Bochum, Schaefers has also completed executive leadership programs and is an active member of industry associations.
 
“I am thrilled to join Simtra BioPharma Solutions at such an exciting time in the company’s growth,” said Schaefers. “I look forward to working with the talented team here to continue building on Simtra’s success and to contribute to the company’s ongoing mission of excellence in the CDMO space.”